In comparison with non-specific breast carcinoma, mucinous breast carcinoma has a favorable prognosis and excellent long-term survival rates, attributed to a lower incidence of nodal involvement, favorable histological grading, and high expression levels of ER and PR, hence paving the way for hormonal therapy as adjuvant treatment [15]. This evidence concerns the gene PGR and breast carcinoma.